Lanean...
Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma
BACKGROUND. The tumor microenvironment after treatment with ipilimumab is not well described. Furthermore, the safety of surgery for patients being treated with ipilimumab for metastatic melanoma has not been well reported. This study analyzed the safety of surgery and the immune phenotype of tumors...
Gorde:
| Argitaratua izan da: | Ann Surg Oncol |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6405339/ https://ncbi.nlm.nih.gov/pubmed/23681603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-2999-1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|